+
  • 1(2).jpg

[Ornithine Aspartate Granules]


Ornithine Aspartate Granulesis indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for early consciousness dysfunction or neurological complications.

Category

product


Ornithine Aspartate Granulesis indicated for treatment of patients with high blood ammonia disease caused by acute and chronic liver disease such as cirrhosis, fatty liver, hepatitis, especially for early consciousness dysfunction or neurological complications.
 
APPLICATIONS
☆  Acute and chronic viral hepatitis
☆  Severe hepatitis
☆  Liver and gallbladder surgery
☆  Tumor radiotherapy and chemotherapy
☆  Alcoholic liver disease and alcohol poisoning;
☆  Fatty liver;
☆  Drug-induced liver injury
 
PRODUCT'S FEATURES
☆  The only biochemical type of live-protecting new drug approved by CFDA during 1998-2004
☆  Supported by National Key Drug Innovation Program, National Key Product
☆  The only generic manufacturer of Ornithine Aspartate in China
☆  High safety
☆  A necessary drug for the treatment of hepatic encephalopathy and acute hepatic coma
☆  Preferred liver-protecting drug in liver transplant
☆  Comprehensively resolve chemical and biological liver problems, protect and enhance liver functions
☆  With reliable curative effects
 
PACKING
3g/sachet * 10 sachets/box
1g/sachet * 10 sachets/box

Online Message

Please leave your cell phone, our professional staff will contact you as soon as possible!

公众号

Copyright © QR Science and Technology All Rights Reserved